Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study.
Kimball, Alexa B, Maurizio Podda, Afsaneh Alavi, Megan Miller, Yaung-Kaung Shen, Shu Li, Yan Xu, et al. 2023. “Guselkumab for the Treatment of Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2 Randomized Study.”. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (10): 2098-2108.